Navigation Links
Endologix to Report Fourth Quarter and Full Year 2010 Financial Results on February 22, 2011
Date:1/20/2011

IRVINE, Calif., Jan. 20, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its fourth quarter and full year 2010 financial results, which will take place on Tuesday, February 22, 2011 after the close of the market.

Endologix will hold a conference call on Tuesday, February 22, 2011 at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results. The dial-in numbers are (877) 407-0789 for domestic callers and (201) 689-8562 for international callers. A live Web cast of the conference call will be available online from the investor relations page of the Company's corporate Web site at www.endologix.com.

After the live Web cast, the call will remain available on Endologix's Web site, www.endologix.com, through March 22, 2011. In addition, a telephonic replay of the call will be available until March 1, 2011. The replay dial-in numbers are (877) 870-5176 for domestic callers and (858) 384-5517 for international callers.  Please use the replay pin number 365657.

About EndologixEndologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's flagship product is the Powerlink® System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's Web site at www.endologix.c
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Endologix to Present at 29th Annual J.P. Morgan Healthcare Conference
2. Endologix Appoints Guido Neels to Its Board of Directors
3. Endologix Completes Acquisition of Nellix
4. Endologix to Host Physician Conference Call to Discuss Nellix Technology on November 11, 2010
5. Endologix Announces First Clinical Implant of Ventana™ Stent Graft
6. Endologix to Acquire Nellix
7. Endologix Reports 30% Third Quarter 2010 Revenue Growth
8. Endologix to Present at Oppenheimer 21st Annual Healthcare Conference
9. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
10. Endologix to Report Third Quarter 2010 Financial Results on October 27, 2010
11. Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... 2014  In a policy paper ... nation,s largest lesbian, gay, bisexual and transgender (LGBT) ... Truvada for Pre-Exposure Prophylaxis (PrEP). PrEP is any ... the spread of a disease or infection prior ... anti-HIV drug combination currently approved for PrEP, which ...
(Date:10/17/2014)... AUSTIN, Texas , Oct. 17, 2014  Hanger, ... it plans to report its results of operations for ... 6, 2014 after the market closes.  A conference call ... 9:00 a.m., ET, on Friday, November 7, 2014. Those ... be available until Friday, November 14, 2014 by dialing ...
(Date:10/17/2014)... Research ... addition of the  "China Interventional Cardiovascular Device ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The ... China impacted by accelerated aging ... dietary habit, way of working and other ...
Breaking Medicine Technology:HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3China Interventional Cardiovascular Device Industry Report 2014-2017 2China Interventional Cardiovascular Device Industry Report 2014-2017 3
... DIEGO , May 6 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... financial results for the first quarter ended March 31, 2010 on ... followed by a live webcast and conference call at 5:00 p.m. Eastern ... Orexigen management will ...
... , May 6 DUSA Pharmaceuticals, Inc. ( DUSA ) announces that its corporate ... 6:30 a.m. to be followed by a conference call at 8:30 a.m. , ... - 8:30 a.m. E.T. , , , ... , , 800-647-4314 , ...
Cached Medicine Technology:Orexigen(R) Therapeutics Schedules May 10, 2010 Webcast Discussion of Financial Results for the First Quarter Ended March 31, 2010 2DUSA Pharmaceuticals, Inc.(R) to Host First Quarter 2010 Corporate Highlights and Financial Results Conference Call 2
(Date:10/20/2014)... 2014 Zereana Jess-Huff, a 34-year-old mother, corporate ... on a platform to think outside the bra. She doesn’t ... position to raise awareness about women’s other lady parts. , ... You say the color pink and everybody knows what you’re ... fact that it has not been won when it comes ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 My Clients ... management software application. The new module enables easy ... receive full life-cycle quality care. , This application allows ... within their practice, attach a to-do item to a ... and even set up reoccurring reminders for follow-ups. ...
(Date:10/20/2014)... AttorneyOne.com, a recognized authority on law, update the ... on Sit and Slim II . , The ... use Sit and Slim II because it contains Sibutramine ... weight loss product on various websites and possibly in some ... for safety reasons, can significantly increase blood pressure and/or pulse ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Rockynol ... Living Center on Oct. 14. The $11 million project ... services, and a cooked-to-order kitchen with full-service restaurant style ... premier choice for first class Assisted Living apartments,” said ... residents deserve the highest quality of care and this ...
(Date:10/20/2014)... Based on a proprietary chromatid-specific ... assays capable of determining DNA sequence, location and ... three dimensions of high-resolution data, dGH assays are ... range of disease-causing genetic rearrangements, including chromosomal inversions ... tools, including today’s advanced sequencing technologies. , According ...
Breaking Medicine News(10 mins):Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:My Clients Plus Announces New Workflow Management Software 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3
... his arms in an accident is getting some high-tech help ... ,Two years ago, a healthy Jesse Sullivan, 56, ... touched a live wire,// costing him both his arms up ... with a traditional artificial prosthesis, relying on chains and buttons ...
... of using a bell and meat powder, which is what ... intrinsic significance and coupled those to food smells," said Dr. ... ,Gottfried was trying to explain what he calls the "restaurant ... your birthday and you have gone though all the appetizers ...
... but gold can. In a remarkable experiment, Indian scientists have developed ... as the 'factory'. ,But before rushing to try cultivating fig trees ... caution : The scientists have been able to use the micro- ... human hair.// ,And therein lies the beauty of the new gold. ...
... Polycystic Ovarian Syndrome(PCOS),a condition which affects women of child-bearing ... testosterone, the so-called male hormone, rendering them unable to ... of facial hair, though scientists have said women// without ... also are a PCOS trait, though women's health experts ...
... one of the most exquisite pieces of engineering in the ... vulnerable to a debilitating degeneration as a result of the ... to blindness. These parts have to be kept from wearing ... lifetime. This, researchers have found, is possible through nutrients that ...
... accompanied by visual disturbances as well as sensitivity ... respond to a drug hitherto used to treat ... that drugs like candesartan cilexetil (Atacand) reduces the ... team decided to study Atacand after a colleague ...
Cached Medicine News:Health News:A man who lost both of his arms in an accident 2Health News:Brain scans show why we always have room for dessert 2Health News:Cultivating gold on a fig tree 2Health News:Polycystic Ovarian Syndrome(PCOS) linked to Diabetes 2Health News:Drug used to treat hypertension effective in countering Migraines 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: